SCHOTT Pharma, a global leader in drug containment and delivery solutions, has announced a binding agreement with TPG, a prominent alternative asset management firm, under which TPG will acquire a...
The Indian government is putting final touches on revised regulations to tighten quality requirements for biosimilar medicines, treatments derived from living cells applied in the treatment of cancers and...
Topiramate hydrochloride tablets from Wockhard Ltd have been approved by Abbreviated New Drug Application, the achievement of the US FDA, announced by Ahmedabad-based Senores Pharmaceuticals Limited.
Akums Drugs & Pharmaceuticals Ltd., a leading Indian pharmaceutical company, just got a patent for a new tablet that’s a game-changer for pregnant women struggling with nausea and vomiting. This exciting invention is here to make pregnancy a littl...
Pharmaceutical representatives will be prevented from meeting with doctors in person at hospitals, according to the major reform suggested by the Health Sector Reform Commission of Bangladesh...
IGI, a global, fully integrated clinical-stage biotechnology company focused on developing multispecifics™ in oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for ISB 2001.
Delhi NCR, May 6th , 2025: Mahajan Imaging & Labs, a pioneer in advanced diagnostics and medical imaging, inaugurated North India’s first 128 Slice Digital PET-CT -Omni Legend by GE HealthCare and state of the art P...
Indian Contract Development and Manufacturing Organisations (CDMOs) like Suven Pharmaceuticals, Syngene International, Laurus Labs, and Divi’s Laboratories are witnessing a surge in demand as global pharma players seek to reduce dependence on...
Biocon Biologics has accomplished a major breakthrough in the U.S. with wide-ranging market access for Yesintek (ustekinumab-kfce), its biosimilar to Stelara, marking its first commercial launch in the country as a fully combined biosimilar company.
A leading contract research and manufacturing organization, Akums Drugs & Pharmaceuticals, has established a patent for its novel extended-release invention of doxylamine and pyridoxine.
, CDSCO.jpg)
